1. Department of Preventive
and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy,
2. Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands,
3. Molecular Cancer Epidemiology Laboratory, Genetics and Computational Division, QIMR Berghofer Medical Research Institute, Brisbane, Australia,
4. School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia,
5. Grupo de Medicina Xenómica-USC, Universidad de Santiago de Compostela, CIBERER, IDIS, Santiago de Compostela, Spain,
6. Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO) and
7. Laboratorio de Oncología Molecular, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain,
8. Center of Familial Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany,
9. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany,
10. Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK,
11. Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain,
12. Oncogenetics Group, Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Barcelona, Spain,
13. Genetic Diagnosis Unit, Hereditary Cancer Program, Institut Català d'Oncologia, Barcelona, Spain,
14. Service de Génétique and INSERM U830, Institut Curie and Université Paris Descartes, Sorbonne Paris Cité, Paris, France,
15. Department of Medicine, The University of Chicago Medical Center, Chicago, IL, USA,
16. Servicio de Oncología Médica, Hospital Clínico San Carlos, Madrid, Spain,
17. Department of Pathology, University of Otago, Christchurch, New Zealand
18. Oncogenetics Group, University Hospital of Vall d'Hebron, Barcelona, Spain